PLA/PLGA Injectable Microspheres

Product Overview

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Injectable

Duration Type: Long-acting

Description: The Shanghai Institute of Planned Parenthood Research (SIPPR) is developing a long-acting, injectable PLA/PLGA microsphere formulation for delivery of LNG for up to 6 months.

Updated date: May 30, 2018

Vertical Tabs

Status

Project Phase: Early Development

Project Stage: Pre-clinical

Began discovery in: 2013

Status Details:
  • In vivo PK data in rats indicates 6-7 months release for select formulations.

Download Product Report